Concepedia

Francisco‐Javier Gamo

FG

Statistics

Publications

89

Citations

7.4K

H-Index

39

Active since

1993

Affiliations

GlaxoSmithKline (Spain)(Current)

Medicines for Malaria Venture

Columbia University Irving Medical Center

University of California San Diego

GlaxoSmithKline (France)

Francisco‐Javier Gamo is an author at GlaxoSmithKline (Spain) specializing in pharmacology, drug discovery, and antimalarial agents.

ORCID

Publications per year

1993–2025

89

Publications

89

Thousands of chemical starting points for antimalarial lead identification

Francisco‐Javier Gamo, Laura M. Sanz, Jaume Vidal et al. · Nature · 2010 · 1K citations

, , +12

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 465 citations · Full text

, , +14

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

Wesley C. Van Voorhis, John H. Adams, Roberto Adelfio et al. · PLoS Pathogens · 2016 · 448 citations · Full text

, , +11

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

Aaron Nilsen, Alexis N. LaCrue, Karen L. White et al. · Science Translational Medicine · 2013 · 302 citations

, , +12

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

José M. Coterón, María Marco, Jorge Esquivias et al. · Journal of Medicinal Chemistry · 2011 · 284 citations · Full text

, , +17

1–5 of 89